WO2016153103A3 - Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition - Google Patents

Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition Download PDF

Info

Publication number
WO2016153103A3
WO2016153103A3 PCT/KR2015/004633 KR2015004633W WO2016153103A3 WO 2016153103 A3 WO2016153103 A3 WO 2016153103A3 KR 2015004633 W KR2015004633 W KR 2015004633W WO 2016153103 A3 WO2016153103 A3 WO 2016153103A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
patient
hair loss
preparing
growth
Prior art date
Application number
PCT/KR2015/004633
Other languages
French (fr)
Korean (ko)
Other versions
WO2016153103A2 (en
Inventor
임재현
Original Assignee
임재현
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/665,740 external-priority patent/US9173921B1/en
Application filed by 임재현 filed Critical 임재현
Priority to JP2016576075A priority Critical patent/JP6823463B2/en
Priority to MX2017012125A priority patent/MX2017012125A/en
Priority to CN201580078177.6A priority patent/CN107708721A/en
Priority to BR112017020132A priority patent/BR112017020132A2/en
Priority to RU2017132712A priority patent/RU2690845C2/en
Priority to CA2979822A priority patent/CA2979822C/en
Priority to AU2015388056A priority patent/AU2015388056B2/en
Priority to EP15886551.9A priority patent/EP3275459A4/en
Publication of WO2016153103A2 publication Critical patent/WO2016153103A2/en
Publication of WO2016153103A3 publication Critical patent/WO2016153103A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a method for promoting hair growth and preventing hair loss of a patient, a composition therefor, and a method for preparing the composition. More particularly, the method for promoting hair growth and preventing hair loss of a patient is characterized in that a composition containing an effective amount of an active ingredient comprising bFGF is intradermally or subcutaneously administered into a lesion of a patient suffering from hair loss. The method for promoting hair growth and preventing hair loss of a patient, the composition therefor, and the method for preparing the composition of the present invention have the effects that new blood vessels are generated in a lesion to thereby increase the supply of blood, and growth of fiber tissues and tissue regeneration are promoted to thus thicken the skin tissue of a lesion.
PCT/KR2015/004633 2015-03-23 2015-05-08 Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition WO2016153103A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2016576075A JP6823463B2 (en) 2015-03-23 2015-05-08 Methods for promoting hair growth and preventing hair loss in patients, as well as compositions for this and methods for producing the same.
MX2017012125A MX2017012125A (en) 2015-03-23 2015-05-08 Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition.
CN201580078177.6A CN107708721A (en) 2015-03-23 2015-05-08 Promote natural on-off cycles of hair growth and the method and composition and manufacture method of pre-Anti-hair loss
BR112017020132A BR112017020132A2 (en) 2015-03-23 2015-05-08 methods for promoting hair growth or preventing hair loss in an individual and for preparing a composition, and,
RU2017132712A RU2690845C2 (en) 2015-03-23 2015-05-08 Method for stimulating hair growth and preventing hair loss of patient, substance therefor and method for producing substance
CA2979822A CA2979822C (en) 2015-03-23 2015-05-08 Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition
AU2015388056A AU2015388056B2 (en) 2015-03-23 2015-05-08 Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition
EP15886551.9A EP3275459A4 (en) 2015-03-23 2015-05-08 Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/665,740 US9173921B1 (en) 2015-03-23 2015-03-23 Method of promoting hair growth by administration of bFGF
US14/665,740 2015-03-23
KR1020150059960A KR101738536B1 (en) 2015-03-23 2015-04-28 Bfgf agent composition for promoting hair growth and the manufacturing method thereof
KR10-2015-0059960 2015-04-28

Publications (2)

Publication Number Publication Date
WO2016153103A2 WO2016153103A2 (en) 2016-09-29
WO2016153103A3 true WO2016153103A3 (en) 2016-11-17

Family

ID=56977343

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/004633 WO2016153103A2 (en) 2015-03-23 2015-05-08 Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition

Country Status (1)

Country Link
WO (1) WO2016153103A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100617644B1 (en) * 2005-03-24 2006-09-05 메디제네스(주) Compositions for treating alopecia or promoting hair growth
KR100796817B1 (en) * 2005-03-23 2008-01-22 정용지 Growth factor for hair and skin treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100796817B1 (en) * 2005-03-23 2008-01-22 정용지 Growth factor for hair and skin treatment
KR100617644B1 (en) * 2005-03-24 2006-09-05 메디제네스(주) Compositions for treating alopecia or promoting hair growth

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DU CROS, D. L. ET AL.: "Distribution of Acidic and Basic Fibroblast Growth Factors in Ovine Skin during Follicle Morphogenesis.", J. CELL SCI., vol. 105, July 1993 (1993-07-01), pages 667 - 674, XP055329022 *
DU CROS, D. L.: "Fibroblast Growth Factor Influences the Development and Cycling of Murine Hair Follicles.", DEV. BIOL., vol. 156, no. 2, April 1993 (1993-04-01), pages 444 - 453, XP024779599 *
GKINI, M. A. ET AL.: "Study of Platelet-Rich Plasma Injections in the Treatment of Androgenetic Alopecia through An One-Year Period.", J. CUT AN. AESTHET. SURG., vol. 7, no. 4, October 2014 (2014-10-01), pages 213 - 219, XP055464390 *
LEE, S. H. ET AL.: "Therapeutic Efficacy of Autologous Platelet-Rich Plasma and Polydeoxyribonucleotide on Female Pattern Hair Loss.", WOUND REPAIR REGEN., vol. 23, no. 1, 13 February 2015 (2015-02-13), pages 30 - 36, XP055328993 *
See also references of EP3275459A4 *

Also Published As

Publication number Publication date
WO2016153103A2 (en) 2016-09-29

Similar Documents

Publication Publication Date Title
MX2017012125A (en) Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition.
WO2017136600A8 (en) Compositions and methods for invasive and non-invasive procedural skincare
WO2012071526A3 (en) Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
WO2010085039A2 (en) Noggin-derived peptide and use thereof
EP3269328A3 (en) Cardiac valve implant
MX2019014410A (en) Methods of treating fabry patients having renal impairment.
WO2018143552A3 (en) Injectable composition for preventing hair loss or stimulating hair growth
EA033298B1 (en) Tesofensine and metoprolol combination formulation
WO2017043953A3 (en) Process for obtaining a sprinkling compound of microvascular endothelial skin cells and mesenchymal stem cells and method of application for tissue regeneration
CA2899775C (en) Compositions and methods for pain relief without numbness
WO2016060917A3 (en) Formulations for histatin therapeutics
EP4295906A3 (en) Treatment of restenosis using temsirolimus
IL267958B1 (en) Composition for injection which can be used for treatment of heart diseases and contains fibroblasts, and method for producing fibroblast for therapy use
EP4410370A3 (en) Compositions for promoting the healing of wounds
WO2019108047A3 (en) Composition for prevention or treatment of hair loss
BR112022015768A2 (en) METHODS OF TREATMENT AND PREVENTION OF GRAFT ARRHYTHMIAS
WO2015140802A3 (en) Delivery system comprising a proteolytic enzyme or effector thereof for use in a method for oral treatment and uses thereof
WO2014116015A3 (en) Composition for preventing alzheimer's disease, containing purple bamboo salt, and method for preparing purple bamboo salt
WO2016153103A3 (en) Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition
WO2019232203A3 (en) Methods and compositions to alleviate vascular permeability
WO2019010301A8 (en) Treatment of heart disease by inhibition of the action of muscle a-kinase anchoring protein (makap)
WO2013087665A3 (en) Composition comprising a carboxylated fructan for epidermis hydratation
NZ713295A (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
MX2022013816A (en) Pharmaceutical composition to be used for increasing hair, modifying scalp or skin, healing wounds, promoting osteogenesis, or modifying hair.
WO2019066548A3 (en) Pharmaceutical composition for prevention or treatment of heart failure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15886551

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2016576075

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2979822

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2017132712

Country of ref document: RU

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2015886551

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: MX/A/2017/012125

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112017020132

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2015388056

Country of ref document: AU

Date of ref document: 20150508

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112017020132

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20170920